Publisher's Synopsis
Drugs in Context is an independent, peer reviewed and practice orientated review of all the significant data on a specific drug, placed in the context of the disease and clinical practice setting. Eprosartan Editorial: "With our wealth of available options we should consider not only what is most likely to work for the individual facing us in our surgery or our clinic, but also what the individual will be willing to take. The problem of compliance or adherence to treatment is an enormous one, particularly in the area of hypertension." Disease Overview: "Lowering elevated blood pressure reduces morbidity from stroke, MI, congestive heart failure and renal failure, and recent outcomes studies have demonstrated that antihypertensive agents offer clinical benefits beyond their blood pressure lowering efficacy." Drug Review: "The side-effect profile of eprosartan is generally superior to that of the alternative antihypertensive agents, specifically in terms of the incidence of ACE inhibitor-induced cough or the headache and oedema that has been associated with sustained release nifedipine.";Improving Practice: "The new GMS contract, published in 2003, is an important step towards the development of primary care in the UK. Of the 550 clinical points available in the GMS contact, 129 relate directly to hypertension."
